Corrigendum: Adenosine kinase on deoxyribonucleic acid methylation: Adenosine receptor-independent pathway in cancer therapy

Front Pharmacol. 2023 Apr 12:14:1200491. doi: 10.3389/fphar.2023.1200491. eCollection 2023.

Hao-Yun Luo¹, Hai-Ying Shen^{2

3}, R Serene Perkins^{4

5}, Ya-Xu Wang¹

¹ Department of Gastrointestinal and Anorectal Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
² Department of Neuroscience, Legacy Research Institute, Portland, OR, United States.
³ Integrative Physiology and Neuroscience, Washington State University, Vancouver, WA, United States.
⁴ Legacy Tumor Bank, Legacy Research Institute, Portland, OR, United States.
⁵ Mid-Columbia Medical Center, The Dalles, OR, United States.

Abstract

[This corrects the article DOI: 10.3389/fphar.2022.908882.].

Keywords: ADK inhibitor; ADK isoforms; DNA methylation; adenosine; adenosine kinase; cancer therapy; receptor-independent pathway.